Rio & Zeyneb
UCLA B.I.G
Undergraduate Summer Program 2016
Xia, Ugoma, & Ashok

Latest News!


  1. Dr. Guanglin Zhang, Dr. Qingying Meng, Montgomery Blencowe’s systems nutrigenomics study was accepted by Molecular Nutrition and Food Research!
  2. Dr. Jason Hong’s pulmonary arterial hypertension paper was accepted by the Blue Journal!
  3. Congratulations to Andrew and Jenny for being admitted to the UCLA IBP MS program
  4. Prof. Xia Yang has won 20-21 UCLA Ctr for Autism Research & treatment Pilot Grant!
  5. Congratulations to Ingrid for being admitted to the UCLA IBP MS program
  6. Congratulations on a successful presentation at QCBIo BIG Summer Epigenomics Journal Club – Alanna, Irika, and Karl
  7. Our lab has won the UCLA CART pilot grant to study autism gene networks! Special thanks to Yanning Zuo who did an extraordinary job for this award to go through
  8. Dr. Insook Ahn’s paper on host genetic background and gut microbiota was accepted by Journal of Nutrition!
  9. Dr. Doug Arneson’s MethylResolver paper was accepted by Communications Biology!

Integrative Genomics and Systems Biology of Common Metabolic Disorders and Comorbidity


Research in our lab employs integrative genomics and systems biology approaches to understand the molecular mechanisms underlying common metabolic disorders including coronary artery disease, diabetes, and obesity. We are also investigating the molecular mechanisms that connect metabolic disorders with brain function and neurological disorders.

Common metabolic disorders represent top health concerns worldwide. Decades of research only reveals greater complexity in the genetic architecture of individual diseases, the connections between them, and the links between metabolic disorders and other diseases. We hypothesize that the complex interactions between genetic and environmental risk factors perturb specific gene networks which in turn induce variations in disease susceptibility and therapeutic response. Click here if you want to learn more about our research.

By applying integrative genomics and systems biology approaches that leverage genetic, transcriptional, epigenomic, and phenotypic data from human and rodent populations, we attempt to identify causal molecular alterations and the subsequently perturbed molecular networks that contribute to the development of obesity, diabetes, cardiovascular diseases, and their comorbidity. In this regard, we have developed Mergeomics and Pharmomics for muti-omics data analysis and drug toxicity & repurposing, respectively. For more details, please click here.

Our research is generously supported by the NIH NIDDK, NINDS, and the NHLBI.

A disease network and key regulators. Figure credit: Jenny Cheng

National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Neurological Disorders and Stroke National Heart, Lung, and Blood Institute